Protein N-glycosylation begins with the assembly of a lipidlinked oligosaccharide (LLO) on the endoplasmic reticulum (ER) membrane. The first two steps of LLO biosynthesis are catalyzed by a functional multienzyme complex comprised of the Alg7 GlcNAc phosphotransferase and the heterodimeric Alg13/Alg14 UDP-GlcNAc transferase on the cytosolic face of the ER. In the Alg13/14 glycosyltransferase, Alg14 recruits cytosolic Alg13 to the ER membrane through interaction between their C-termini. Bioinformatic analysis revealed that eukaryotic Alg14 contains an evolved N-terminal region that is missing in bacterial orthologs. Here, we show that this N-terminal region of Saccharomyces cerevisiae Alg14 localize its green fluorescent protein fusion to the ER membrane. Deletion of this region causes defective growth at 38.5°C that can be partially complemented by overexpression of Alg7. Coimmunoprecipitation demonstrated that the N-terminal region of Alg14 is required for direct interaction with Alg7. Our data also show that Alg14 lacking the N-terminal region remains on the ER membrane through a nonperipheral association, suggesting the existence of another membrane-binding site. Mutational studies guided by the 3D structure of Alg14 identified a conserved α-helix involved in the second membrane association site that contributes to an integral interaction and protein stability. We propose a model in which the N-and C-termini of Alg14 coordinate recruitment of catalytic Alg7 and Alg13 to the ER membrane for initiating LLO biosynthesis.
Protein N-glycosylation begins with the assembly of a lipidlinked oligosaccharide (LLO) on the endoplasmic reticulum (ER) membrane. The first two steps of LLO biosynthesis are catalyzed by a functional multienzyme complex comprised of the Alg7 GlcNAc phosphotransferase and the heterodimeric Alg13/Alg14 UDP-GlcNAc transferase on the cytosolic face of the ER. In the Alg13/14 glycosyltransferase, Alg14 recruits cytosolic Alg13 to the ER membrane through interaction between their C-termini. Bioinformatic analysis revealed that eukaryotic Alg14 contains an evolved N-terminal region that is missing in bacterial orthologs. Here, we show that this N-terminal region of Saccharomyces cerevisiae Alg14 localize its green fluorescent protein fusion to the ER membrane. Deletion of this region causes defective growth at 38.5°C that can be partially complemented by overexpression of Alg7. Coimmunoprecipitation demonstrated that the N-terminal region of Alg14 is required for direct interaction with Alg7. Our data also show that Alg14 lacking the N-terminal region remains on the ER membrane through a nonperipheral association, suggesting the existence of another membrane-binding site. Mutational studies guided by the 3D structure of Alg14 identified a conserved α-helix involved in the second membrane association site that contributes to an integral interaction and protein stability. We propose a model in which the N-and C-termini of Alg14 coordinate Introduction N-glycosylation is an essential posttranslational modification of proteins occurring in eukaryotes. It begins with the multistep biosynthesis of a highly conserved lipid-linked oligosaccharide (LLO), which is extended by a series of membrane-associated Alg (asparagine-linked glycosylation) glycosyltransferases to produce Glc 3 Man 9 GlcNAc 2 -PP-dolichol in the endoplasmic reticulum (ER). Assembly of the first seven sugars in the LLO synthetic pathway takes place on the cytoplasmic face of the ER membrane and is catalyzed by cytosolic glycosyltransferases that produce Man 5 GlcNAc 2 -PP-dolichol from the soluble nucleotide sugar substrates uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) and GDP-Man. Six enzymes involved in this stepwise cytoplasmic biosynthesis have been identified. Interestingly, these enzymes are organized into two functional multiglycosyltransferase complexes. The first complex catalyzes the conversion of dolichol-P to GlcNAc 2 -PP-dolichol (Noffz et al. 2009) , and the other functions as a multimannosyltransferase complex that sequentially transfers the next five mannoses from GDP-mannose to GlcNAc 2 -PP-dolichol (Gao et al. 2004 ). The resulting Man 5 GlcNAc 2 -PP-dolichol intermediate is then flipped across the bilayer into the ER in an adenosine triphosphate-independent manner by a specific ER flippase (Sanyal et al. 2008; Sanyal and Menon 2009a,b) . Six glycosyltransferases oriented toward the ER lumen subsequently catalyze the further addition of seven sugars (four mannoses and three glucoses) derived from the dolichol-sugar substrates Man-P-dolichol and Glc-P-dolichol to complete the LLO biosynthetic process (Hirschberg and Snider 1987; Lennarz 1987; Schenk et al. 2001; Helenius and Aebi 2004) . Defects in LLO biosynthesis lead to diseases known as type I congenital disorders of glycosylation, underscoring the biological and clinical importance of Glc 3 Man 9 GlcNAc 2 -PP-dolichol (Aebi and Hennet 2001; Haeuptle and Hennet 2009; Dupre et al. 2010; Rind et al. 2010 ).
The cytoplasmic multiglycosyltransferase complex that catalyzes the initial two steps of LLO synthesis consists of a UDPGlcNAc-1-P transferase (Alg7p/GPT) encoded by the ALG7 gene and a heterodimeric UDP-GlcNAc transferase, Alg13/14 (Noffz et al. 2009 ). Alg7p (GPT) transfers GlcNAc-1-P from UDP-GlcNAc to the polyisoprenoid-acceptor dolichol phosphate to form GlcNAc-PP-dolichol (Barnes et al. 1984; Kukuruzinska and Robbins 1987; Lehrman 1991) and is the sole eukaryotic member of the UDP-D-N-acetylhexosamine, a polyprenol phosphate D-N-acetylhexosamine 1-phosphate transferase superfamily (Lehrman 1994; Price and Momany 2005) . Bacterial orthologs of Alg7 include MraY, which catalyzes the first membrane-associated step of peptidoglycan biosynthesis in Escherichia coli to form undecaprenylpyrophosphoryl-MurNAc-pentapeptide (Lipid I) (Ikeda et al. 1991; Bouhss et al. 1999; van Heijenoort 2001; van Heijenoort 2007) . The second step in LLO synthesis, in which GlcNAc-PP-dolichol is extended to GlcNAc 2 -PP-dolichol, is catalyzed by Alg13/14 glycosyltransferase and utilizes UDP-GlcNAc as the donor substrate (Bickel et al. 2005; Chantret et al. 2005; Gao et al. 2005) . Similarly, the bacterial homolog of Alg13/14 glycosyltransferase, MurG, catalyzes the second membrane-associated step of peptidoglycan synthesis to yield GlcNAc-MurNAc-pentapeptide-PP-undecaprenol (Lipid II) by transferring a single GlcNAc from UDP-GlcNAc to Lipid I (Mengin- Lecreulx et al. 1991; Ha et al. 2001) . MurG binds to the bacterial membrane despite the absence of any transmembrane domains (TMDs; Bupp and van Heijenoort 1993; Mohammadi et al. 2007 ). Analysis of the crystal structure of MurG led to the identification of a hydrophobic patch that is believed to associate with the cytosolic surface of lipid bilayers (Ha et al. 2000; Ha et al. 2001) . Biochemical and structural analyses have revealed enzymatic and topological similarities between Alg7 and MraY and between Alg13/Alg14 glycosyltransferase and MurG (Bugg and Brandish 1994; Bouhss et al. 1999; Burda and Aebi 1999; Price and Momany 2005; Bouhss et al. 2008) , suggesting that the first two steps of N-glycosylation share a common evolutionary origin with those of peptidoglycan synthesis. Noffz et al. (2009) proposed that the formation of the eukaryotic Alg7/13/14 complex contributes to the efficiency and the regulation of LLO synthesis; however, there is no direct evidence supporting this idea. To obtain a better understanding of the mechanisms that control and coordinate N-glycosylation in eukaryotic cells, deciphering the molecular mechanism of complex formation among Alg7, Alg13 and Alg14 is of critical importance.
Previously, we elucidated the mechanism of the interaction between Alg13 and Alg14 to form the heterodimeric Alg13/14 glycosyltransferase in Saccharomyces cerevisiae (Gao et al. 2008) . During complex formation, Alg14 functions as a membrane anchor that recruits Alg13 to the cytosolic face of the ER as a result of interaction between their C-terminal regions (Gao et al. 2005; Gao et al. 2008) . Based on algorithm analysis, the N terminus of Alg14 was recently predicted to contain a TMD of 5-24 amino acids, and the existence of additional peripherally attached membrane-associated domains is also indicated based on analyses of Alg13-Alg14 chimeras (Averbeck et al. 2007 ). However, because bioinformatics predictions are limited and fusion proteins influence the properties or structure of Alg14, we conducted a functional analysis focusing on the N-terminal region of Alg14 using a native protein from yeast. Here, we provide clear evidence that the N-terminal region of Alg14 not only contributes to its localization to the ER membrane, but also is required for direct interaction with Alg7. Our data also indicate that the second membrane association site involves a conserved amphiphilic-like α-helix located in the central part of Alg14 and that this site mediates an integral interaction with the ER. Together, these findings implicate Alg14 as the core coordinator in the recruitment of the catalytic partners Alg7 and Alg13 to the ER membrane to initiate N-glycosylation.
Results
The evolved N-terminal region of Alg14 localizes GFP fusion protein to the ER membrane Sequence alignment and structural studies revealed that the N-terminal region of S. cerevisiae Alg14 contains a predicted TMD (residues 5-24) that is missing in E. coli MurG UDP-GlcNAc transferase (Averbeck et al. 2007; Gao et al. 2008) . Database searches showed that this N-terminal region of Alg14 is present in all eukaryotic orthologs from fungi to Specific roles of Alg14 in the initiation of N-glycosylation humans, but is not present in bacterial UDP-GlcNAc transferases ( Figure 1A ), indicating its topological evolution in eukaryotes. This finding prompted us to examine the biological role played by this N-terminal region in eukaryotic N-glycosylation.
To confirm whether the N-terminal region is involved in membrane associations, we directly fused the first 47 amino acids of Alg14 with the N terminus of the cytosolic expression of green fluorescent protein (GFP; Figure 1B ) and examined its subcellular localization. Fluorescence microscopy showed that the Alg14N-GFP fusion protein colocalizes with the ER marker KmRFP, suggesting that the 47 attached residues tether cytosolic GFP to the ER ( Figure 1C ). Subcellular fractionation of the proteins prepared from this Alg14N-GFP strain, and western blot analysis with anti-GFP antibodies confirmed that Alg14N-GFP localizes predominantly in the ER membrane-enriched fraction (data not shown). Together, these results demonstrated that the N-terminal region is sufficient to target a heterologous marker to the ER membrane.
Deletion of the Alg14 N-terminal region causes a severe growth defect at high temperature To explore the in vivo function of the N-terminal region further, we constructed a series of plasmids expressing truncated ALG14 mutant alleles encoding truncated variants lacking 47 (3FLAG-alg14NΔ47), 54 (3FLAG-alg14NΔ54) or 62 (3FLAG-alg14NΔ62) N-terminal amino acids (Table I ). The N terminus of each variant was tagged with a triple N-terminal FLAG epitope to facilitate detection. A schematic diagram of the Alg14 mutant proteins lacking the TMD is shown in Figure 2A . Noticeably, amino acids 55-62 are predicted to form the first β-sheet (Figure 2A ) involved in the formation of the Rossmann fold (Gao et al. 2008) . Deletion of the first 62 amino acids completely destroys this first β-sheet and is predicted to destabilize and inactivate the protein.
The function of the mutant alleles was analyzed by introducing them into the XGY151 strain, in which chromosomal ALG14 is under the control of the glucose-repressible GAL1 promoter, and their ability to complement the loss of Alg14 when grown on glucose medium was assayed. This complementation experiment showed that deletion of up to 54 of Alg14's N-terminal amino acids has no effect on cell growth, while deletion of 62 amino acids fails to rescue the growth defect caused by repression of the ALG14 gene ( Figure 2B ). To test whether this was due to protein instability, 1% Triton X-100 extracts prepared from each strain were analyzed by western blot using an anti-FLAG antibody. This experiment revealed that both the normal and truncated Alg14 proteins are expressed at relatively similar levels, with the exception of Alg14NΔ62, which is barely detectable by western blot ( Figure 2C ). These results indicated that Alg14 with a deleted N-terminal region functions as well as the wild-type protein and also demonstrate that this region is unnecessary for cell viability under the tested condition.
To analyze the phenotypes caused by loss of the TMD in more detail, we constructed a yeast strain (XGY200) that expresses a 3FLAG-tagged Alg14NΔ47 protein as the only Alg14. The alg14NΔ47-expressing cells (XGY200) exhibited a significant growth defect after the temperature was raised to 38.5°C ( Figure 3A ), but at 25 or 30°C growth was comparable to that of wild-type cells (XGY199) that express only a 3FLAG-tagged wild-type Alg14 ( Figure 3A ). In addition, analyses of hygromycin B sensitivity, invertase mobility and western blotting of CPY revealed no marked differences between the alg14NΔ47-expressing and wild-type cells (data not shown). Interestingly, the temperature-sensitive phenotype could be partially complemented by overexpression of Alg7, which is another member of the first heterooligomeric glycosyltransferase complex ( Figure 3B ), suggesting that there is a This study pXG221 3FLAG-alg14NΔ47 expressed from ALG14 promoter in pRS306
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direct functional interaction between Alg7 and Alg13/Alg14 complexes.
The N-terminal region of Alg14 is required for interaction with Alg7
To determine whether deletion of the N-terminal region of Alg14 is required for formation of the Alg7/13/14 complex, coimmunoprecipitation assays were performed. Yeast strains (XGY209 and XGY210) that coexpress N-terminal 3FLAG-tagged Alg14 or Alg14NΔ47 with N-terminal 3HA-tagged Alg7 were constructed. Detergent extracts were prepared, proteins were immunoprecipitated with anti-HA antibodies, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with anti-FLAG antibodies. As shown in Figure 4A , 3HA-Alg7 coprecipitated with FLAG-Alg14 but not with FLAG-Alg14NΔ47, indicating that the N-terminal region of Alg14 is required for interaction with Alg7. Detergent extracts were also prepared from yeast strains (XGY211 and XGY212) that coexpress N-terminal 3FLAG-tagged Alg14 or Alg14NΔ47 with N-terminal 3HA-tagged Alg13, and 3HA-tagged Alg13 precipitated both FLAG-Alg14NΔ47 and FLAG-Alg14, suggesting that deletion of the Alg14 N-terminal region does not interfere with its interaction with Alg13 ( Figure 4B ). These results are in agreement with our previous study, which demonstrated that Alg13 and Alg14 interact through their C-termini (Gao et al. 2008 ). This experiment also suggests that Alg13 does not directly interact with Alg7 because Alg14NΔ47 pulled down Alg13 but not Alg7.
Together, these results demonstrate that the N-terminal region of Alg14 is involved in mediating the interaction with Alg7.
Protein distribution and membrane extraction data suggest a second membrane association site in Alg14
To determine whether deletion of the N-terminal region affects the intracellular localization of Alg14, we performed a series of analyses on native Alg14 and its mutant variants. The sedimentation properties of 3FLAG-tagged Alg14NΔ47 and 3FLAG-tagged Alg14 were compared by subcellular fractionation. Lysates prepared from XGY200 cells expressing 3FLAG-Alg14NΔ47 and XGY199 cells expressing 3FLAG-Alg14 were subjected to differential centrifugation to separate ER membranes (P13 fraction), lighter membrane components (P100 fraction) including the Golgi apparatus and small transport vesicles and soluble cytosolic proteins (S100 fraction). An equivalent amount of protein from each fraction was separated by SDS-PAGE and immunoblotted with is under control of the glucose-repressible GAL1 promoter (P GAL1 ) was transformed with URA3/ CEN6 integration plasmids containing 3FLAG-ALG14 ( pXG220), 3FLAG-alg14NΔ47 ( pXG221), 3FLAG-alg14NΔ54 ( pXG222) or 3FLAG-alg14NΔ62 ( pXG223) and streaked onto YPA plates supplemented with galactose (YPAG plate, right panel) or glucose (YPAD plate, left panel). Cells were incubated at 30°C for 2 days. (C) Yeast cells described above were grown to mid-log phase in YPAG medium and their detergent extracts were prepared as described earlier. Protein (50 μg) from each sample was separated by 12% SDS-PAGE and quantitatively analyzed by immunoblotting using an anti-FLAG M2 monoclonal antibody conjugated to alkaline phosphatase, and detected by chemiluminescence. ) that coexpress 3HA-ALG7 together with 3FLAG-ALG14 and 3FLAG-ALG14NΔ47, or express only 3HA-ALG7. (B) Detergent extracts were also prepared from yeast strains (XGY211 and XGY212) that coexpress 3HA-ALG13 together with 3FLAG-ALG14 and 3FLAG-ALG14NΔ47, or express only 3HA-ALG13. Extract samples were then immunoprecipitated with an anti-HA affinity matrix. Immunoprecipitated proteins were separated by 12% SDS-PAGE, immunoblotted using rabbit anti-FLAG antibodies followed by a secondary anti-rabbit antibody conjugated to alkaline phosphatase and detected by chemiluminescence (A and B, lanes 1-3). To directly detect 3FLAG-tagged Alg14 variants (A and B, lanes 4-6), 3HA-tagged Alg7 (A, lanes 7-9) or 3HA-tagged Alg13 (B, lanes 7-9) in detergent extracts, samples were subjected to western blotting using an anti-FLAG M2 monoclonal antibody conjugated to alkaline phosphatase or an anti-HA monoclonal antibody conjugated to peroxidase and detected by chemiluminescence. Dpm1p in the detergent extracts (B, lanes 10-12) was also subjected to western blotting as loading control of the experiment. Crude extracts were prepared from yeast strains (XGY199 and XGY200) expressing 3FLAG-ALG14 or 3FLAG-ALG14NΔ47 and the subcellular fraction was analyzed as described earlier. Protein (10 μg) from each fraction was separated by 12% SDS-PAGE and analyzed by immunoblotting using antibodies against FLAG-tagged proteins, Dpm1 (an ER marker) or Ynd1 (a Golgi apparatus marker). (B) The ER membrane fraction prepared from XGY199 and XGY200 cells was treated with 0.2% SDS or 100 mM Na 2 CO 3 ( pH 11) and further centrifuged at 100,000 × g to separate membrane and soluble proteins as described earlier. Equivalent amounts from the pellet (P) and supernatant (S) were analyzed by western blot.
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anti-FLAG antibody to detect Alg14 proteins ( Figure 5 ). As was the case with Alg14, the majority of Alg14NΔ47 fractionated with the ER membrane, cosedimenting with the ER protein Dpm1 but not the Golgi marker Ynd1 (Gao et al. 1999 ) ( Figure 5A ). This result demonstrated that deletion of the N-terminal region does not appreciably affect the membrane distribution of Alg14 and suggests that there is an as yet undefined second membrane-binding site in Alg14.
To study this second membrane association in more detail, ER membranes were extracted using alkaline sodium carbonate, which releases peripheral but not integral membrane proteins, and the proteins released were compared with those released using 0.2% SDS detergent treatment. As shown in Figure 5B , there was no significant difference between intact Alg14 and Alg14NΔ47. The N-terminal-truncated Alg14 mutant protein was released from the ER membrane by 0.2% SDS, but clearly resisted alkaline sodium carbonate ( pH 11) extraction. Taken together, our results suggest that, like native Alg14, Alg14NΔ47 also associates with the ER membrane in a nonperipheral manner.
Structural analysis suggests a conserved α-helix domain in Alg14 is involved in membrane association To gain information about the additional membrane association site, structural analyses were conducted using the stereo model of the yeast Alg13/14 complex ( Figure 6A ) and compared with the structure of E. coli MurG (1F0K) ( Figure 6B ). The 3D structure of the yeast Alg13/14 complex was modeled based on an Alg13 structure (2jzc) (Wang et al. 2008) determined by nuclear magnetic resonance and the predicted secondary structure of Alg14 (Chantret et al. 2005 ) using MurG as a guide. The credibility of the 3D structural model was previously validated by its accurate prediction of the interaction A helical wheel plot of the Alg14 helix α3 amino acid sequence was constructed using a free program (http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). Central line divides residues into hydrophobic and more polar faces. The hydrophobic residues are presented in red circles, potentially positively charged residues in black and other residues in blue. (D) Schematic view of the amphiphilic nature of yeast Alg14 helix α3. The illustration shown here was generated on the basis of the Alg14 structure predicted by phyre Ver.2 (http://www.sbg.bio.ic.ac.uk/~phyre/). Helix α3 is shown as a ribbon. Some residues are labeled with the amino acid numbers corresponding to the Alg14 sequence.
Specific roles of Alg14 in the initiation of N-glycosylation region between Alg13 and Alg14 (Gao et al. 2008) . In this study, we focused on the helix Nα3 domain of E. coli MurG (see Figure 1C of Gao et al. (2008) for the detailed secondary structure of MurG), which is highly exposed on the surface of MurG ( Figure 6B , circled in black). This α-helix domain is believed to be the primary structure of the membrane association interface in MurG because it contains most of the conserved hydrophobic and basic residues that have been predicted to directly interact with the bacterial membrane (Ha et al. 2000) . Structural analyses revealed that the third α-helix (α3) of Alg14 (see Figure 1C of Gao et al. (2008) for the detailed secondary structure of Alg14) is a homolog structure of MurG helix Nα3 (Chantret et al. 2005; Gao et al. 2008) and that it is also conserved among the eukaryotic Alg14s (data not shown). As shown in Figure 6A , Alg14 helix α3 (black circle) is also exposed on the surface of Alg13/Alg14 glycosyltransferase. Amino acid sequence analysis of this domain revealed that more than half of its residues are hydrophobic and, most remarkably, a helical wheel projection indicated that the hydrophobic and two positively charged residues are arranged to one side of the helix ( Figure 6C and D, hydrophobic face). Such an exposed amphiphilic-like α-helix would be expected to associate with the cytosolic monolayer of the lipid bilayer membrane through its hydrophobic face (Helenius et al. 2008) , suggesting that Alg14 helix α3 serves as the second membrane association site. Figure 6D , red) were replaced with A residues were introduced into the P GAL1 -ALG14 strain (XGY151) to test for complementation of the loss of Alg14 when grown on glucose medium. As shown in Figure 7A , the Alg14-mut6A protein completely rescued the loss of Alg14 function in the P GAL1 -ALG14 cells, indicating that the mut6A (V   131   , I 135 , V 139 , V 143 , V 146 and F 150 replaced with As) substitution had no deleterious effect on Alg14 activity. However, the growth of P GAL1 -ALG14 cells expressing Alg14NΔ47-mut6A was extremely slow at 30°C, indicating the presence of a combined growth defect caused by the loss of the N-terminal TMD and the mutation on Alg14 helix α3. Interestingly, a similar 3FLAG-tagged Alg14NΔ47-mut6 protein in which V 131 was replaced with I, I
135 was replaced with L, V 139 , V 143 and V
146
were replaced with I, and F 150 was replaced with L (hydrophobic mut6 substitution), was able to rescue the loss of Alg14 function in the P GAL1 -ALG14 cells ( Figure 7A ). Because the hydrophobic mut6 substitution maintains the hydrophobic properties of Alg14 helix α3, this result conclusively proved that the hydrophobic property imparted by these six residues is critical to the biological function of Alg14NΔ47. These results agree with our previous membrane extraction experiment ( Figure 5B) and structural analysis ( Figure 6 ) that suggested Alg14 integrally associates with the ER membrane through the hydrophobic face of helix α3.
To examine the membrane distribution and stability of Alg14, mutant proteins were fractionated and analyzed by western blot. In agreement with the complementation test, we found 3FLAG-Alg14-mut6A sediments in the membrane fraction at the same level as Alg14 and Alg14NΔ47 ( Figure 7B,  lanes 1, 2 and 3) . Remarkably, however, there was significantly less Alg14NΔ47-mut6A in both the membrane and soluble fractions ( Figure 7B, lane 4) , suggesting that the mutant protein had been degraded. In contrast, degradation did not affect expression of Alg14NΔ47-hydrophobic mut6, as evidenced by the fact that its stability and membrane distribution were comparable to that of Alg14NΔ47 ( Figure 7B , lane 5). Taken together, our results indicate that the hydrophobic face of helix α3 is not directly required for Alg14 cell viability, but that its loss combined with the loss of the N-terminal TMD destabilizes the protein. under control of the glucose-repressible GAL1 promoter (P GAL1 ) was transformed with URA3/CEN6 integration plasmids containing 3FLAG-ALG14 ( pXG220), 3FLAG-alg14NΔ47 ( pXG221), 3FLAG-alg14-mut6A ( pWF5), 3FLAG-alg14NΔ47-mut6A ( pWF6) or 3FLAG-alg14NΔ47-hydrophobic mut6 ( pWF7) genes, and streaked onto YPA plates supplemented with glucose. Cells were incubated for 2 days at 30°C. (B) Distribution of Alg14 mutant variants. Whole-cell extracts prepared from the strains described above were further separated into soluble protein-containing supernatant fractions (SF100) and membrane protein-containing pellet fractions (PF100) as described in "Materials and Methods". Equal volumes of each sample were subjected to western blot analysis using anti-FLAG antibody to detect the 3FLAG-tagged Alg14 variants and anti-Dpm1 antibody to detect the Dpm1p.
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The hydrophobic face of helix α3 is required for the membrane association of Alg14NΔ47 It is known that residues G 163 and G 165 are part of a conserved glycine-rich loop (G-loop) in yeast Alg14 (Chantret et al. 2005) . To define the importance of G-loop to the membrane association of Alg14NΔ47, plasmids expressing 3FLAG-tagged Alg14 or Alg14NΔ47 in which G 163 and G 165 were replaced with A residues (G163A-G165A substitution) were constructed and expressed in P GAL1 -ALG14 cells (XGY151). We examined the effect of the G163A-G165A substitution on the function and membrane distribution of Alg14 or Alg14NΔ47 and compared it to that of the mut6A substitution. As shown in Figure  8A , the Alg14-G163A-G165A protein completely failed to rescue the loss of Alg14 function in the P GAL1 -ALG14 cells, indicating that unlike the mut6A substitution, the G163A-G165A substitution destroyed the function, as we predicted. Interestingly, Alg14-G163A-G165A showed a stable membrane distribution comparable to that of wild-type Alg14, as did its derivative, Alg14NΔ47-G163A-G165A ( Figure 8B, lanes 1 and 3) . Noticeably, even though Alg14NΔ47-G163A-G165A retained an intact helix α3, the protein was inactivated by the loss of conserved G-loop. When considered in light of the degradation of Alg14NΔ47-mut6A ( Figure 7B , lane 4, and Figure 8B , lane 2), this result strongly suggests that helix α3 is indispensable for the stable membrane distribution of Alg14NΔ47 variants.
To determine whether the Alg14NΔ47-mut6A protein has enzymatic activity, we overexpressed Alg14NΔ47-mut6A in XGY151 cells using a multicopy expression vector and evaluated their growth phenotype on glucose medium. As clearly shown in Figure 8A , overexpression of Alg14NΔ47-mut6A completely rescued the growth defect caused by the loss of Alg14 function in P GAL1 -ALG14 cells, while Alg14NΔ47-mut6A expressed by an integration (single copy) vector failed to do so. Western blot analysis further confirmed that expression of mutant protein in the membrane fraction was recovered in Alg14NΔ47-mut6A overexpressing cells, although the distribution in the soluble fraction also increased ( Figure 8B , lane 4). Furthermore, the Alg14NΔ47-mut6A overexpressed strain exhibits the same growth phenotype as the Alg14NΔ47 mutant (data not shown). These data demonstrate that the Alg14NΔ47-mut6A protein retains some ability to form an active complex with Alg13 on the ER membrane, although we cannot exclude the possibility that its function is also be compromised to some extent. Taken together, our data strongly suggest that degradation of Alg14NΔ47-mut6A is caused by the loss of its membrane association rather than its function.
Discussion
The Alg7/13/14 UDP-GlcNAc transferase complex catalyzes the first two steps of LLO biosynthesis. A growing body of evidence indicates that formation of this complex is a critical regulatory point in the N-linked glycosylation pathway. Results from our previous study suggested that Alg14 recruits cytosolic Alg13 to the ER membrane through interaction between their C-termini (Gao et al. 2008) . To elucidate the molecular mechanism that mediates the interaction between Alg7, Alg13 and Alg14 in more detail, we performed molecular biological analyses focusing on a conserved N-terminal region of eukaryotic Alg14.
We began by investigating the molecular and cellular functions of the Alg14 N-terminal region of yeast, and using its GFP fusion protein (Alg14N-GFP) demonstrated that the N-terminal domain is associated with the ER membrane ( Figure 1C ). Considering the ER luminal orientation of the Alg14 N terminus (Averbeck et al. 2007; Nishimura et al. 2009 ), it can be concluded from our results that the predicted N-terminal α-helix of Alg14 functions as a TMD. The P GAL1 -ALG14 strain (XGY151) was transformed with URA3/CEN6 integration plasmids containing 3FLAG-ALG14 ( pXG220), 3FLAG-alg14-G163A-G165A ( pWF8) or 3FLAG-alg14NΔ47-mut6A ( pWF6), and streaked onto YPA plates supplemented with glucose. For the overexpression experiment, XGY151 was transformed with an LEU2/2μ yeast expression plasmid containing 3FLAG-alg14NΔ47-mut6A ( pWF10). Cells were incubated at 30°C for 2 days. (B) Wild-type strain (W303a) was transformed with URA3/CEN6 integration plasmids containing 3FLAG-ALG14 ( pXG220), 3FLAG-alg14Δ47-G163A-G165A ( pWF9), 3FLAG-alg14NΔ47-mut6A ( pWF6) or a LEU2/2μ shuttle plasmid containing 3FLAG-alg14NΔ47-mut6A ( pWF10) and cultured at 30°C. Whole-cell extracts prepared from these strains were further separated into soluble protein-containing supernatant fractions (SF100) and membrane protein-containing pellet fractions (PF100) as described earlier. Equal volumes of each sample were subjected to western blot analysis using anti-FLAG antibody to detect the 3FLAG-tagged Alg14 variants.
Specific roles of Alg14 in the initiation of N-glycosylation
The most important feature of the Alg14 N-terminal region was defined by coimmunoprecipitation, which provided clear evidence for its direct interaction with Alg7 ( Figure 4A ). Alg7 also functions as an ER membrane protein like Alg14, but is predicted to contain 10 TMDs. Our data here do not reveal which part of Alg7 is involved in the interaction with Alg14. However, it is conceivable that one or more of these TMDs directly interact with the N-terminal TMD of Alg14 since transmembrane α-helices often physically connect with one another to mediate protein-protein interactions (Helenius et al. 2008) . Membrane topological analysis of Alg7 is needed to unravel the molecular details of how this multipletransmembrane protein interacts with the N-terminal region of Alg14.
Unlike the association between Alg13 and Alg14, which is essential for their function, the interaction between Alg14 and Alg7 seems to have no effect on normal cell growth because the growth of a yeast strain that expresses only a 3FLAG-tagged Alg14NΔ47 protein was comparable to the wild-type strain at 30°C ( Figure 3A) . However, we discovered that removal of the N-terminal region of Alg14 causes a severe growth defect when the temperature is raised to 38.5°C (Figure 3) , providing a strong indication of the physiological importance of this N-terminal domain. This raises the question of how this conserved N-terminal region benefits eukaryotic cells. One obvious advantage is that interaction between the N-terminal regions of Alg14 and Alg7 may improve the efficiency of N-glycosylation. The level of ALG7 expression is a determinant of LLO pool in yeast cell (Mendelsohn et al. 2005) . Formation of the Alg7/13/14 complex has been predicted to enable channeling of their intermediates between successive active sites without diffusion (Noffz et al. 2009 ). Our data showing that overexpression of Alg7 partially compensates for the temperature-sensitive growth phenotype ( Figure 3B ) of Alg14NΔ47 cells are in agreement with this idea because overexpression of Alg7 would be expected to produce more GlcNAc-PP-dolichol intermediate, thereby improving the efficiency of LLO synthesis.
The N-terminal region may also serve a redundant function with another membrane-associated domain. Deletion of the N-terminal TMD does not affect the membrane distribution of Alg14 ( Figure 5A ), confirming that a second membrane association site exists. Subsequent alkaline extraction of the ER membrane showed that the second membrane-associated domain is integrally associated with the ER membrane ( Figure 5B ). However, this result is inconsistent with those of a previous report, which indicated a peripheral attachment between Alg14 and the membrane fraction. The authors of that report utilized the same extraction method described here, except for the use of a chimeric Alg13-Alg14 fusion protein instead of native Alg14 (Averbeck et al. 2007) . It is well known that formation of the native Alg13/Alg14 glycosyltransferase complex is based on the interaction between Alg13 and Alg14 mediated through their C-termini (Gao et al. 2008) , but the chimeric Alg13-Alg14 fusion protein was engineered by fusing the C-terminus of Alg14ΔTMD with the N terminus of Alg13 (Averbeck et al. 2007 ). We attribute the inconsistent membrane association phenotype to this chimeric construction, which may have disturbed the protein's nascent conformation and thus altered its behavior with respect to Alg14NΔ47.
Since most algorithms predict a single TMD topology for Alg14, it is likely that the second membrane-associated domain does not span the ER membrane as its N-terminal TMD does. This hypothesis is consistent with the idea that Alg14NΔ47 shares a similar membrane association mechanism with its bacterial homolog MurG because, like Alg14NΔ47, MurG has no TMD, but associates with the bacterial membrane, and this association is not affected by the presence of high salts or alkaline conditions (Mohammadi et al. 2007 ). The third α-helix of the MurG N-terminal domain (Nα3) has been predicted to be involved in membrane association (Ha et al. 2000) . By comparing a computational model of yeast Alg13/14 complex with the stereo structure of bacterial MurG, we confirmed that the third α-helix (α3) of Alg14 is homologous to Nα3. Alg14 helix α3 also possesses a hydrophobic face involving two basic residues and is located in an exposed position in the Alg13/14 complex, as is the case with Nα3 in MurG ( Figure 6 ). Most importantly, this amphiphilic-like α-helix (α3) is conserved among all eukaryotic Alg14 proteins. In addition to the structural evidence, our molecular biological approach demonstrated that the combined loss of the hydrophobic face of helix α3 and the N-terminal TMD destabilizes Alg14 (Figure 7) . Furthermore, our overexpression experiment suggested that Alg14NΔ47-mut6A retains activity to form an active complex with Alg13 on the ER membrane (Figure 8 ). It is reasonable to conclude that degradation of Alg14NΔ47-mut6A is not caused by the loss of its function on the ER membrane, but rather by the loss of its ability to associate with the ER membrane. Such an explanation is further supported by our analysis of another Alg14 mutant protein, Alg14NΔ47-G163-165A, which lacks both the N-terminal TMD and G-loop, but retains the native helix α3. Although Alg14NΔ47-G163-165A completely failed to form an active complex with Alg13, its membrane distribution was comparable to that of wild-type Alg14 ( Figure 8B, lanes 1 and 3) , indicating that helix α3 is required for keeping this inactive mutant Alg14 on the ER membrane and preventing its degradation. Considering both the structural and biological evidence including algorithmic information, we conclude that as is the case with bacterial MurG helix Nα3, helix α3 mediates an integral membrane association of Alg14 through its hydrophobic face. Our biological study provided the first such evidence, experimentally proving that an α-helix domain in proteins of the GT-B glycosyltransferase family is required for membrane association.
Compared with bacterial MurG, the evolved N-terminal region domain brought an additional transmembrane site to eukaryotic Alg14. Given the complexity of biosynthetic processes and cytosolic membrane-enclosed organelles like the ER and Golgi apparatus in eukaryotic cells, such a multibinding site system not only guarantees the accurate and stable localization of Alg14 on the ER membrane, but also contributes to the formation of the multienzyme complex as described above. It was recently reported that the yeast mannosyltransferases Alg1 (Gao unpublished data), Alg2 and Alg11, which are members of the multimannosyltransferase complex that catalyzes the steps subsequent to the Alg7/13/14 complex in LLO synthesis, have a "dispensable" N-terminal TMD similar to Alg14 (Kampf et al. 2009; Absmanner et al. 2010) , indicating that such membrane topology may be a general feature of Alg glycosyltransferases. Considering the fact that Alg1, Alg2 and Alg11 physically interact as do Alg7, Alg13 and Alg14 (Gao et al. 2004) , our findings concerning the N-terminal region of Alg14 underscore the biological importance of the conserved N-terminal structures and enhance understanding of the mechanism by which the Alg glycosyltransferase complexes are organized.
Based on our structural analyses of Alg14, we propose a model for how the Alg7/13/14 multienzyme complex is formed, in which Alg14 acts as a central scaffold that is anchored tightly to the ER surface through two different binding sites and recruits two catalytic partners, Alg7 and Alg13, to form the multiglycosyltransferase complex that initiates N-glycosylation ( Figure 9 ). Our data also clearly suggest that the mechanism of membrane association is different between eukaryotes and prokaryotes, since MurG lacks the additional N-terminal region found in Alg14. From a practical viewpoint, these data provide new insights that may impact the design of specific antibiotics that target the interaction of MurG with the bacterial membrane.
Materials and methods

Plasmids, yeast strains and growth conditions
The plasmids and yeast strains used in this study are described in Tables I and II , respectively. Standard molecular biological techniques were used for plasmid construction (Guthrie and Fink 1991) , and the QuikChange™ site-directed mutagenesis kit (Stratagene, La Jolla, California) was used to generate various alg14 mutant genes. The correct sequences of all polymerase chain reaction (PCR)-amplified products were verified by DNA sequencing. The sequences of primers used in plasmid construction are available upon request. All Alg14-and Alg14-variant proteins were tagged with a triple FLAG epitope at the N terminus and were expressed from the ALG14 promoter. The Alg7 and Alg13 proteins were N-terminally tagged with a triple HA epitope and were expressed from the constitutive triose-phosphate isomerase (TPI1) promoter. Plasmid pSA20 expresses an ALG14N47-GFP fusion gene under control of the TPI1 promoter and contains the 5′-region of the ALG14 ORF encoding the first 47 amino acids in frame with a GFP gene lacking its initiating ATG. Plasmid pSA21 expresses an ER marker using monomeric red fluorescent protein (RFP) encoded by the KAR2-mRFP-HDEL (KmRFP) fusion gene (Gao et al. 2005) under control of the glyceraldehyde-3-phosphate dehydrogenase (TDH3) promoter.
S. cerevisiae W303a (MATa his3-11 leu2-3, 112 ura3-1 trp1-1 ade2-1 can1-100) was the parent of all strains used in this work. The XGY151 strain contains a replacement of the chromosomal ALG14 promoter with the glucose-repressible GAL1/10 promoter (Gao et al. 2005) and was used to test the activity of Alg14 mutant proteins by monitoring compensation for the lethality associated with the loss of ALG14 function. Strain XGY199 was constructed from strain XGY151 and contains a replacement of the chromosomal GAL1-driven ALG14 allele with the E. coli kan r gene, kanMX4 (which confers resistance to G418/geneticin). To compensate for the lethality caused by the deletion of chromosomal ALG14, As in W303a and alg14::kanMX4 ALG14pr-3FLAG-ALG14::URA3 This study XGY200
As in W303a and alg14::kanMX4 ALG14pr-3FLAG-alg14NΔ47::URA3 This study XGY209
As in XGY199 and TPI1pr-3HA-ALG7::LEU2 This study XGY210
As in XGY200 and TPI1pr-3HA-ALG7::LEU2 This study XGY211
As in XGY199 and TPI1pr-3HA-ALG13::LEU2 This study XGY212
As in XGY200 and TPI1pr-3HA-ALG13::LEU2 This study Fig. 9 . Schematic representation of Alg7/13/14 complex formation on the cytosolic face of the ER membrane. Alg14 anchoring to the ER membrane is mediated by its N-terminal TMD and a predicted membrane-binding interface. The TMD spins through the lipid bilayer and interacts with the multitransmembrane glycosyltransferase Alg7, which transfers a GlcNAc-phosphate to dolichol phosphate. The membrane-binding interface is located in the middle of the protein and is assumed to associate with the cytosolic monolayer of the lipid bilayer. Alg13 interaction with Ag14 is mediated by its C-terminal α-helix in cooperation with C-terminal amino acids of Alg14 to form a dimeric Alg13/14 UDP-GlcNAc transferase, which catalyzes the production of GlcNAc 2 -PP-dolichol.
Specific roles of Alg14 in the initiation of N-glycosylation pXG220 containing a 3FLAG-tagged ALG14 allele under its own promoter (Table I ) was integrated at the ura3 locus before the replacement (disruption of GAL1-driven ALG14). Strain XGY200 was constructed using the same strategy but contains an additional 3FLAG-tagged alg14NΔ47 allele under its own promoter integrated at the ura3 locus ( pXG221). For coimmunoprecipitation experiments, XGY209-212 strains were constructed by integrating 3HA-ALG7-expressing pWF3 or 3HA-ALG13-expressing pWF4 (Table I) into strains XGY199 or XGY200 at the leu2 locus, respectively. Replacement of promoters or chromosomal loci was carried out by PCR-mediated recombination (Baudin et al. 1993 ) using the standard pFA6a-series of plasmids as templates (Longtine et al. 1998) . Standard yeast media, growth conditions and genetic techniques were used (Guthrie and Fink 1991) .
Analysis of GFP and mRFP fusion proteins
To visualize the localization of Alg14N54-GFP and KmRFP fusion proteins, wild-type (W303a) cells were transformed with pSA20 and pSA21 and grown to an OD 600 of 1-3 in YPAD medium. After washing the cells with PBS + 2% glucose, GFP fluorescence was imaged using a NIBA filter (Olympus, Tokyo, Japan) and mRFP fluorescence was imaged using a WIG filter (Olympus) on an Olympus IX72 microscope.
Preparation of detergent extracts, western blotting and coimmunoprecipitation Exponentially growing yeast cells were harvested at an OD 600 of 1-3 and converted to spheroplasts with lyticase (Gao and Dean 2000) . Spheroplasts (6-7 OD units) were resuspended and incubated in 500 µL of ice-cold lysis buffer (150 mM NaCl, 10 mM HEPES-KOH ( pH 7.5), 5 mM MgCl 2 ) with protease inhibitors and 1% Triton X-100 for 10 min. Epitope-tagged proteins in detergent extracts were separated by 10-12% SDS-PAGE and transferred to an Immobilon-PVDF membrane (Millipore, Billerica, Massachusetts). The membrane was then incubated with either an anti-FLAG M2 monoclonal antibody conjugated to alkaline phosphatase (Sigma-Aldrich, St. Louis, Missouri) or a mouse anti-HA monoclonal antibody conjugated to peroxidase (Anti-[HA]-Peroxidase, Roche), and protein was detected by chemiluminescence (CDP-Star Detection Reagent, Roche or ECL, GE Healthcare, Little Chalfont, UK). For coimmunoprecipitation experiments, 3HA-tagged Alg7 or Alg13 was immunoprecipitated with anti-HA Affinity Matrix (Sigma-Aldrich) as described elsewhere (Gao et al. 2005) . After separating proteins by 12% SDS-PAGE, immunoprecipitates were transferred to an Immobilon-PVDF membrane (Millipore). To detect FLAG-tagged Alg14 proteins, the membrane was incubated with a rabbit anti-FLAG polyclonal antibody (Rockland, Inc., Gilbertsville, PA) followed by a secondary anti-rabbit antibody conjugated to alkaline phosphatase (Chemicon International, Billerica, MA).
Subcellular fractionation and membrane extraction
Fifty OD 600 units of exponentially growing yeast cells (about 2 × 10 9 cells) were harvested and incubated in 1 mL of A-Buffer (100 mM EDTA, 0.5% β-Me, 10 mM Tris-HCl, pH 9.5) for 15 min at 30°C and then resuspended in 0.8 mL of S-Buffer (1.0 M sorbitol, 2 mM MgCl 2 , 0.14% β-Me, 50 mM Tris-HCl, pH 7.5) with Zymolyase 100T (Seikagaku Co., Tokyo, Japan) at a concentration of 50 U/OD 600 . After incubating at 30°C for 10-20 min (during which time about 70% of the cells were converted to spheroplasts), spheroplasts were collected and washed twice with ice-cold S-Buffer. The cells were then suspended in 1 mL of lysis buffer (0.2 M sorbitol, 1 mM EDTA, 50 mM Tris-HCl, pH 7.5) containing protease inhibitors and transferred to a Dounce Homogenizer (Wheaton Scientific, Millville, New Jersey). Cells were lysed with 20 strokes of a Teflon pestle while kept on ice and then centrifuged at 1000 × g for 10 min to remove unlysed cells and cell wall debris. The supernatant was carefully collected as crude extract and then centrifuged at 13,000 × g for 15 min, yielding the P13 pellet and the S13 supernatant. The S13 fraction was centrifuged at 100,000 × g for 60 min to yield the P100 pellet and S100 supernatant. Together with the crude extract and S100 fraction, the P13 and P100 fractions were resuspended in suitable amounts of lysis buffer, and protein concentrations were determined using the BCA Protein Assay (Thermo Fisher Scientific, Waltham, Massachusetts). For membrane extraction, the ER membrane fraction (P13) was resuspended in 100 μL of TE ( pH 7.2) containing 0.2% SDS or 100 mM Na 2 CO 3 ( pH 11). Samples were incubated for 30 min on ice and then centrifuged at 100,000 × g for 15 min. The supernatants (S) were removed from the pellets (P), which were brought up to 100 μL with Laemmli sample buffer. Equivalent amounts of each sample were separated by 12% SDS-PAGE and immunoblotted using an anti-FLAG antibody as described above.
To make the membrane fraction that was used in western blot experiments of Figures 7 and 8, 1 mL of crude extract prepared from 50 OD 600 yeast cells was directly centrifuged at 100,000 × g for 30 min. This generated the soluble proteincontaining supernatant fraction (SF100) and the membranecontaining pellet fraction (PF100), which was resuspended in 100 µL of lysis buffer containing protease inhibitors and 1% Triton X-100.
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